SARAH LASALA: Open Payments
NPI 1205327566 · ENFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,284 in 144 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $2,047 · 2025 $3,284
Food & beverage: $3,275Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $446 |
| UCB, Inc. | 21 | $398 |
| LEO Pharma Inc. | 8 | $355 |
| Janssen Biotech, Inc. | 16 | $315 |
| Novartis Pharmaceuticals Corporation | 17 | $286 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $256 |
| Galderma Laboratories, L.P. | 11 | $229 |
| Incyte Corporation | 8 | $224 |
| E.R. Squibb & Sons, L.L.C. | 7 | $152 |
| Arcutis Biotherapeutics, Inc. | 5 | $100 |
Products named: Bimzelx, TREMFYA, ADBRY, OPZELURA, SKYRIZI, RINVOQ, NEMLUVIO, ILUMYA.
Industry payments across CT — which companies pay providers there.
